Ankur M. Shah, M.D.

Ankur M. Shah, M.D.

Sub-Specialty:

Macula-Retina-Vitreous Services

Practice:

Raj K. Maturi, M.D., P.C.
317-817-1414

Online Payment Portal

Ankur ShahPatient-Care Specialties

Macular Degeneration, Diabetic Retinopathy, Macular Edema, Macular Holes and Puckers, Retinal Detachments and Tears, Genetic Ocular Conditions, Retinal Vascular Occlusions, Retinal and Choroidal dystrophies and disorders.

Diagnostic Services and Procedures

Ocular Coherence Tomography, Digital Photography, Fluorescein Angiography, OPTOS Ultra-wide field Angiography, Multifocal Electroretinography, Ganzfeld Electroretinography, B-Scan Ultrasonography

Intravitreal Injections, Retinal Laser Photocoagulation, Pneumatic Retinopexy, Cryoretinopexy, Vitreous, Macular and Retinal Surgery

Education

M.D.   Northwestern University, Feinberg School of Medicine, Chicago, IL-2002 – 2006

Alpha Omega Alpha (AOA) Medical Honor Society, 2006

B.S.    University of Michigan, Ann Arbor, MI-1998 - 2001

Biological Anthropology with Highest Distinction

Residency

Ophthalmology       University of California – San Diego, Shiley Eye Center, San Diego, CA 2007 – 2010

Chief Resident        University of California – San Diego, Shiley Eye Center, San Diego,CA 2009 – 2010

Fellowship

Surgical Retina        University of Chicago, Chicago, IL

                             2014 – 2016

Medical Retina        Northwestern University, Chicago, IL

                             2010 – 2011

Professional Affiliations

American Academy of Ophthalmology (AAO)
American Society of Retina Specialists (ASRS)
Association for Research in Vision and Ophthalmology (ARVO)
Club Vit

Research

Publications

Shah AM, Grewal D. Which treatment paradigm local or systemic therapy – best treats bilateral noninfectious uveitis?

Point/Counter: Ocular Surgery News U.S. Edition, March 10, 2020

Gupta N, Shah AM, Jampol LM, Gill, MK. Intravitreal Bevacizumab for Choroidal Metastases Secondary to Adenocarcinoma of the Lung.

Clinical Communications – Oncology.  2015:2:2.

Shah AM, Bressler NM, Jampol LM. Does Laser Still Have a Role in the Management of Retinal Vascular and Neovascular Diseases?

American Journal of Ophthalmology 2011;152(3):332-339.

Shah AM, Oster SF, Freeman WR.  Viral Retinitis After Intravitreal Triamcinolone Injection in Patients with Predisposing Medical Comorbidities.

American Journal of Ophthalmology 2010;149(3):433-440.

Abstracts and Presentations

“YUTIQ CALM: a real-world registry study of the fluocinolone acetonide intravitreal implant 0.18 mg in chronic non-infectious posterior uveitis.”  Shah AM.  Presented at American Society of Retinal Specialists Annual Meeting. San Antonio, TX. October 9, 2021.

Intravitreal Bevacizumab for Choroidal Metastases Secondary to Adenocarcinoma of the Lung.” Shah AM, Gill MK, Jampol LM.  Presented at American Society of Retinal Specialists Annual Meeting. Boston, MA. August 22, 2011.

Viral Retinitis After Intravitreal Triamcinolone Injection in Patients with Predisposing Medical Comorbidities.” Shah AM, Oster SF, Freeman WR.  Presented at Shiley Eye Center Alumni Research Day, La Jolla, CA.  June 19, 2010.

Principal Investigator Protocols

COAST, (OPT-3002-1005) A phase III, multicenter, double-masked, randomized study to evaluate the efficacy and safety of Intravitreal OPT-302 in combination with Aflibercept, compared with Aflibercept alone, in participants with Neovascular Age-Related Macular Degeneration, 2021

BALATON, (GR41984) A phase III, multicenter, randomized, double-masked, active comparator–controlled study to evaluate the efficacy and safety of Faricimab in patients with Macular Edema secondary to Branch Retinal Vein Occlusion, 2021

COMINO, (GR41986) A phase III, multicenter, randomized, double-masked, active comparator–controlled study to evaluate the efficacy and safety of Faricimab in patients with Macular Edema secondary to Central Retinal or Hemiretinal Vein Occlusion, 2021

AVONELLE-X, (GR42691) A multicenter, open-label extension study to evaluate the long-term safety and tolerability of Faricimab in patients with Neovascular Age-Related Macular Degeneration, 2021

THE NEW DAY STUDY, (01-20-005) A randomized, masked, controlled study of intravitreal Iluvien Implant as baseline therapy in patients with early Diabetic Macular Edema, 2020

RHONE-X, (GR41987) A multicenter, open-label extension study to evaluate the long-term safety and tolerability of Faricimab in patients with Diabetic Macule edema, 2020

NORSE III (ONS-5010-003) A 3-month study to assess the safety of ONS-5010 in subjects with visual impairment due to retinal disorders, 2020

PHOTON, (VGFTe-HD-DME-1934), A randomized, double-masked, active-controlled phase 2/3 study of the efficacy and safety of high-dose Aflibercept in patients with Diabetic Macular Edema, 2020

TALON, (CRTH258A2303), A 64-week, two-arm, randomized, double-masked, multicenter, phase III study assessing the efficacy and safety of Brolucizumab 6 mg compared to Aflibercept 2 mg in a treat-to-control regimen in patients with neovascular age-related macular degeneration, 2019

KINGFISHER, (RTH258B2305), A 12-month, 2-arm, randomized, double-masked, multicenter phase III study assessing the efficacy and safety of Brolucizumab every 4 weeks versus Aflibercept every 4 weeks in adult patients with visual impairment due to Diabetic Macular Edema, 2019

NORSE II, (ONS-5010-002), A clinical effectiveness, multicenter, randomized, double-masked, controlled study of the efficacy and safety of ONS-5010 in subjects with subfoveal choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD), 2019

LUCERNE, (GR40844), A phase III, multi-center, randomized, double-masked, active comparator-controlled study to evaluate the efficacy and safety of Faricimab in patients with neovascular age-related macular degeneration, 2019

RHINE, (GR40398), A phase III, multicenter, randomized, double masked, active comparator-controlled study to evaluate the efficacy and safety of R06867461 (Faricimab) in patients with Diabetic Macular Edema, 2018

Safety and Efficacy of Suprachoroidal CLS-TA in Combination with an Intravitreal Anti-VEGF Agent in Subjects with Retinal Vein Occlusion, 2018

Sub-Investigator Protocols

LONGITUDE, (BP41783) A longitudinal, biomarker study of Anti-VEGF, to explore the relationship between aqueous humor composition and multimodal retinal imaging in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema, 2021

Lpath / Pfizer Pharmaceuticals, Sub-Investigator, Efficacy and Safety Study of iSONEP With and Without Lucentis/Avastin to Treat Age-related Macular Degeneration (AMD) (Nexus), 2014-2015.

XOMA, Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis (EYEGUARD™-A), 2014-2016.

XOMA, Sub-Investigator, Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled with Systemic Treatment (EYEGUARD™-C), 2014-2016.

XOMA, Sub-Investigator, An Open-label, Rollover Study Providing Continued Dosing of Gevokizumab in Order to Assess Long-term Gevokizumab Safety Data (EYEGUARD™-E), 2014-2015.

Santen, Sub-Investigator, A Phase III, Multinational, Multicenter, Randomized, Double-Masked, Study for the Treatment of Active, Non-Infectious Uveitis (SAKURA), 2015-2016.

LECTURES

Developments in the Management of Diabetic Retinopathy & Diabetic Macular Edema
2019    Glaucoma – Cataract Consultants, Inc. Annual Optometric CME Event

Vitreomacular Interface Disorders
2016    Prairie Eye Center Fall Optometric CME Symposium

The Evolving Role of Intravitreal Steroids in the Management of Diabetic Macular Edema
2016    University of Chicago Dept. of Ophthalmology and Visual Sciences Annual Research Day

Peripheral Retinal Pathology
2015    Illinois College of Optometry

Vitreoretinal Interface Disorders
2015    Glaucoma – Cataract Consultants, Inc. Annual Optometric CME Event

Peripheral Retinal Pathology
2015    Glaucoma – Cataract Consultants, Inc. Annual Optometric CME Event

>Vitreoretinal Interface Disorders,br>2014    University of Chicago Ophthalmology Residency Lecture Series

The Role of Vitreomacular Adhesion in Retinal Vascular and Neovascular Disease
2013    Wisconsin Academy of Ophthalmology Eye MD Symposium

Peripheral Retinal Pathology
2012    Wisconsin Optometric Association Summer Education Event

Diabetic Retinopathy
2012    Wisconsin Optometric Association Summer Education Event

Diabetic Retinopathy
2012    Aurora St. Luke’s Family Practice Residency Lecture Series

Diabetic Retinopathy
2012    Aurora St. Luke’s Endocrinology Group

Vitreoretinal Interface Disorders
2011    Northwestern University Ophthalmology Residency Lecture Series

Age-Related Macular Degeneration
2010    Northwestern University Ophthalmology Residency Lecture Series

Back to Our Providers >>